In the global fight against HIV/AIDS, reliable access to antiretroviral drugs like Efavirenz is paramount. Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is a cornerstone of combination therapy, helping millions manage the virus. When paired with formulations or adjuvants (such as “Castor,” which may refer to specialized delivery systems or regional adaptations), Efavirenz Castor becomes a targeted solution for diverse healthcare needs. For pharmaceutical manufacturers and exporters, identifying a curated Efavirenz Castor Global Buyers List is critical to scaling distribution, ensuring affordability, and supporting global health equity. This article outlines the importance of such a list, key markets, buyer segments, and actionable strategies to connect with top purchasers. Understanding Efavirenz…